ATE405587T1 - Immunotherapeutische methoden mit verwendung von wt-1 and gata-1 epitopen - Google Patents
Immunotherapeutische methoden mit verwendung von wt-1 and gata-1 epitopenInfo
- Publication number
- ATE405587T1 ATE405587T1 AT05023645T AT05023645T ATE405587T1 AT E405587 T1 ATE405587 T1 AT E405587T1 AT 05023645 T AT05023645 T AT 05023645T AT 05023645 T AT05023645 T AT 05023645T AT E405587 T1 ATE405587 T1 AT E405587T1
- Authority
- AT
- Austria
- Prior art keywords
- peptide
- gata
- epitopes
- polypeptide
- variant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9823897.5A GB9823897D0 (en) | 1998-11-02 | 1998-11-02 | Immunotherapeutic methods and molecules |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE405587T1 true ATE405587T1 (de) | 2008-09-15 |
Family
ID=10841650
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05023645T ATE405587T1 (de) | 1998-11-02 | 1999-11-02 | Immunotherapeutische methoden mit verwendung von wt-1 and gata-1 epitopen |
AT99952682T ATE316099T1 (de) | 1998-11-02 | 1999-11-02 | Immunotherapeutische methoden mit verwendung von wt-1 and gata-1 epitopen |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99952682T ATE316099T1 (de) | 1998-11-02 | 1999-11-02 | Immunotherapeutische methoden mit verwendung von wt-1 and gata-1 epitopen |
Country Status (14)
Country | Link |
---|---|
US (3) | US7326767B1 (de) |
EP (2) | EP1619202B1 (de) |
JP (2) | JP2003500004A (de) |
AT (2) | ATE405587T1 (de) |
AU (1) | AU770752B2 (de) |
CA (2) | CA2348956C (de) |
CY (1) | CY1105597T1 (de) |
DE (2) | DE69929533T2 (de) |
DK (1) | DK1127068T3 (de) |
ES (2) | ES2252982T3 (de) |
GB (1) | GB9823897D0 (de) |
NZ (1) | NZ511454A (de) |
WO (1) | WO2000026249A1 (de) |
ZA (1) | ZA200103943B (de) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1178956C (zh) | 1998-07-31 | 2004-12-08 | 杉山治夫 | 基于癌抑制基因wt1的产物的癌抗原 |
US7115272B1 (en) | 1998-09-30 | 2006-10-03 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
US7655249B2 (en) | 1998-09-30 | 2010-02-02 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
US7901693B2 (en) | 1998-09-30 | 2011-03-08 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
US7329410B1 (en) | 1998-09-30 | 2008-02-12 | Corixa Corporation | Compositions and method for WT1 specific immunotherapy |
US20030235557A1 (en) * | 1998-09-30 | 2003-12-25 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
GB9930616D0 (en) | 1999-12-24 | 2000-02-16 | Mathilda & Terence Kennedy Ins | Activation and inhibition of the immune system |
CN100421727C (zh) | 2000-12-22 | 2008-10-01 | 玛蒂尔达和特伦斯·肯尼迪风湿病学信托学会 | 方法 |
KR100863853B1 (ko) | 2001-03-22 | 2008-10-15 | 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 | 더블유티1 개변 펩티드 |
WO2003002142A1 (en) * | 2001-06-29 | 2003-01-09 | Chugai Seiyaku Kabushiki Kaisha | Cancer vaccine containing cancer antigen based on tumor suppressor gene wt1 product and cationic liposomes |
US7553494B2 (en) | 2001-08-24 | 2009-06-30 | Corixa Corporation | WT1 fusion proteins |
EP1447091A4 (de) | 2001-09-28 | 2008-02-13 | Institute Of Can International | Neues verfahren zur induktion von antigen-spezifischen t-zellen |
JPWO2003028758A1 (ja) * | 2001-09-28 | 2005-01-13 | 治夫 杉山 | 抗原特異的t細胞の誘導方法 |
AU2003262094A1 (en) * | 2002-09-12 | 2004-04-30 | Haruo Sugiyama | Cancer antigen peptide preparation |
ES2332590T3 (es) * | 2003-01-15 | 2010-02-09 | International Institute Of Cancer Immunology, Inc. | Dimero peptidico. |
JP4566912B2 (ja) | 2003-06-27 | 2010-10-20 | 株式会社癌免疫研究所 | Wt1ワクチン適応患者の選択方法 |
CA2548135C (en) * | 2003-12-01 | 2014-04-22 | Sloan-Kettering Institute For Cancer Research | Synthetic hla binding peptide analogues and uses thereof |
GB0328363D0 (en) | 2003-12-06 | 2004-01-14 | Imp College Innovations Ltd | Therapeutically useful molecules |
GB0406415D0 (en) * | 2004-03-22 | 2004-04-21 | Inst Of Cancer Res The | Materials and methods for treatment of cancer |
DK2186896T3 (en) | 2004-03-31 | 2015-12-21 | Int Inst Cancer Immunology Inc | Cancer antigen peptides derived from WT1 |
PL1642905T3 (pl) * | 2004-10-02 | 2009-04-30 | Immatics Biotechnologies Gmbh | Epitopy immunogenicznych komórek pomocniczych T z antygenów guzów ludzkich oraz sposoby immunoterapeutyczne wykorzystujące te epitopy |
WO2007047764A2 (en) | 2005-10-17 | 2007-04-26 | Sloan Kettering Institute For Cancer Research | Wt1 hla class ii-binding peptides and compositions and methods comprising same |
ES2352855T3 (es) | 2005-11-30 | 2011-02-23 | International Institute Of Cancer Immunology, Inc. | Nuevos compuestos peptídicos del tumor de wilms. |
US9265816B2 (en) | 2006-04-10 | 2016-02-23 | Sloan Kettering Institute For Cancer Research | Immunogenic WT-1 peptides and methods of use thereof |
CN105664147A (zh) | 2007-02-07 | 2016-06-15 | 日本电气株式会社 | 用于癌症的治疗剂 |
MX343633B (es) | 2007-03-05 | 2016-11-11 | Int Inst Cancer Immunology Inc | Gen receptor de celulas t especificas de antigeno cancerigeno, peptido codificado por el gen, y uso de los mismos. |
CN101888852B (zh) | 2007-12-05 | 2017-02-08 | 株式会社癌免疫研究所 | 癌症疫苗组合物 |
GB0917094D0 (en) | 2009-09-29 | 2009-11-11 | Ucl Biomedica Plc | T-cell receptor |
WO2013002086A1 (ja) | 2011-06-28 | 2013-01-03 | 株式会社癌免疫研究所 | ペプチド癌抗原特異的t細胞のレセプター遺伝子 |
AU2012291101B2 (en) | 2011-07-29 | 2016-04-07 | Riken | Cell for use in immunotherapy which contains modified nucleic acid construct encoding Wilms tumor gene product or fragment thereof, method for producing said cell, and said nucleic acid construct |
US20140341939A1 (en) | 2011-12-14 | 2014-11-20 | National University Corporation Kochi University | Modification of helper t cell-inducing polypeptide |
JP6282598B2 (ja) | 2012-01-13 | 2018-02-21 | メモリアル スローン ケタリング キャンサー センター | 免疫原性wt1ペプチド及びその使用方法 |
SG11201407175RA (en) * | 2012-05-03 | 2014-12-30 | Hutchinson Fred Cancer Res | Enhanced affinity t cell receptors and methods for making the same |
US10815273B2 (en) | 2013-01-15 | 2020-10-27 | Memorial Sloan Kettering Cancer Center | Immunogenic WT-1 peptides and methods of use thereof |
CA2898099A1 (en) | 2013-01-15 | 2014-07-24 | David A. Scheinberg | Immunogenic wt-1 peptides and methods of use thereof |
ES2694328T3 (es) | 2013-03-12 | 2018-12-19 | Sumitomo Dainippon Pharma Co., Ltd. | Composición acuosa líquida |
AU2014244860B2 (en) | 2013-03-29 | 2018-07-26 | International Institute Of Cancer Immunology, Inc. | WT1-antigen peptide conjugate vaccine |
US10588952B2 (en) | 2013-03-29 | 2020-03-17 | Sumitomo Dainippon Pharma Co., Ltd. | Conjugate vaccine using trimming function of ERAP1 |
CN107073090A (zh) | 2014-04-30 | 2017-08-18 | 哈佛学院董事会 | 结合的疫苗装置和杀死癌细胞的方法 |
US10023841B2 (en) * | 2014-05-23 | 2018-07-17 | Baylor Research Institute | Methods and compositions for treating breast cancer with dendritic cell vaccines |
CA2956545A1 (en) | 2014-08-04 | 2016-02-11 | Fred Hutchinson Cancer Research Center | T cell immunotherapy specific for wt-1 |
US11318163B2 (en) | 2015-02-18 | 2022-05-03 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
US11596652B2 (en) | 2015-02-18 | 2023-03-07 | Enlivex Therapeutics R&D Ltd | Early apoptotic cells for use in treating sepsis |
US11304976B2 (en) | 2015-02-18 | 2022-04-19 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
IL284985B2 (en) | 2015-02-18 | 2023-03-01 | Enlivex Therapeutics R& D Ltd | Combined immunotherapy and cytokine control therapy for cancer treatment |
US11000548B2 (en) | 2015-02-18 | 2021-05-11 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
US11497767B2 (en) | 2015-02-18 | 2022-11-15 | Enlivex Therapeutics R&D Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
EP3285877B1 (de) | 2015-04-21 | 2022-10-19 | Enlivex Therapeutics Rdo Ltd | Therapeutische gepoolte blutapoptotische zellpräparate und verwendungen davon |
JP7138864B2 (ja) | 2016-02-06 | 2022-09-20 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 免疫を再構成するための造血ニッチの再現 |
CA3014885A1 (en) | 2016-02-18 | 2017-08-24 | Enlivex Therapeutics Ltd. | Combination immune therapy and cytokine control therapy for cancer treatment |
CN115404196A (zh) | 2016-07-13 | 2022-11-29 | 哈佛学院院长等 | 抗原呈递细胞模拟支架及其制备和使用方法 |
WO2018227205A1 (en) * | 2017-06-09 | 2018-12-13 | President And Fellows Of Harvard College | Compositions for inducing an immune response |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5726288A (en) | 1989-11-13 | 1998-03-10 | Massachusetts Institute Of Technology | Localization and characterization of the Wilms' tumor gene |
JP3393867B2 (ja) * | 1989-11-13 | 2003-04-07 | マサチユーセツツ・インステイテユート・オブ・テクノロジー | ウィルムス腫瘍遺伝子の位置決定と特徴付け |
AU7774291A (en) | 1990-05-10 | 1991-11-27 | Toshio Tsuyuki | Device and method for feeding information |
CA2069541C (en) | 1992-05-26 | 2005-02-01 | Cornelis J. M. Melief | Induction of an antigen-specific t-lymphocyte response |
US5622835A (en) * | 1994-04-28 | 1997-04-22 | The Wistar Institute Of Anatomy & Biology | WT1 monoclonal antibodies |
DK0879282T3 (da) | 1996-01-17 | 2003-10-20 | Imp College Innovations Ltd | Immunterapi ved anvendelse af cytotoksiske T-lymfocytter (CTL) |
JPH10218093A (ja) | 1997-02-05 | 1998-08-18 | Suzuki Motor Corp | 船外機 |
CN1178956C (zh) * | 1998-07-31 | 2004-12-08 | 杉山治夫 | 基于癌抑制基因wt1的产物的癌抗原 |
DE69938970D1 (de) * | 1998-09-30 | 2008-08-07 | Corixa Corp | Zusammensetzungen und verfahren für wt1-spezifische immunotherapie |
US7144581B2 (en) * | 2000-10-09 | 2006-12-05 | Corixa Corporation | Compositions and methods for WT1 specific immunotherapy |
US7063854B1 (en) * | 1998-09-30 | 2006-06-20 | Corixa Corporation | Composition and methods for WTI specific immunotherapy |
-
1998
- 1998-11-02 GB GBGB9823897.5A patent/GB9823897D0/en not_active Ceased
-
1999
- 1999-11-02 ES ES99952682T patent/ES2252982T3/es not_active Expired - Lifetime
- 1999-11-02 AT AT05023645T patent/ATE405587T1/de not_active IP Right Cessation
- 1999-11-02 EP EP05023645A patent/EP1619202B1/de not_active Revoked
- 1999-11-02 NZ NZ511454A patent/NZ511454A/xx not_active IP Right Cessation
- 1999-11-02 ES ES05023645T patent/ES2311915T3/es not_active Expired - Lifetime
- 1999-11-02 CA CA2348956A patent/CA2348956C/en not_active Expired - Fee Related
- 1999-11-02 JP JP2000579636A patent/JP2003500004A/ja active Pending
- 1999-11-02 AT AT99952682T patent/ATE316099T1/de active
- 1999-11-02 DE DE69929533T patent/DE69929533T2/de not_active Expired - Lifetime
- 1999-11-02 EP EP99952682A patent/EP1127068B1/de not_active Revoked
- 1999-11-02 WO PCT/GB1999/003572 patent/WO2000026249A1/en active IP Right Grant
- 1999-11-02 DE DE69939406T patent/DE69939406D1/de not_active Expired - Lifetime
- 1999-11-02 DK DK99952682T patent/DK1127068T3/da active
- 1999-11-02 CA CA2773380A patent/CA2773380A1/en not_active Abandoned
- 1999-11-02 AU AU64797/99A patent/AU770752B2/en not_active Ceased
-
2000
- 2000-07-26 US US09/625,963 patent/US7326767B1/en not_active Expired - Fee Related
-
2001
- 2001-05-15 ZA ZA200103943A patent/ZA200103943B/en unknown
-
2006
- 2006-04-03 CY CY20061100465T patent/CY1105597T1/el unknown
-
2007
- 2007-07-06 US US11/825,578 patent/US8529904B2/en not_active Expired - Fee Related
-
2012
- 2012-05-07 JP JP2012105984A patent/JP2012183067A/ja active Pending
-
2013
- 2013-08-14 US US13/966,454 patent/US20140199762A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2348956A1 (en) | 2000-05-11 |
ES2252982T3 (es) | 2006-05-16 |
JP2012183067A (ja) | 2012-09-27 |
US20140199762A1 (en) | 2014-07-17 |
ES2311915T3 (es) | 2009-02-16 |
GB9823897D0 (en) | 1998-12-30 |
DK1127068T3 (da) | 2006-05-08 |
CY1105597T1 (el) | 2010-07-28 |
CA2773380A1 (en) | 2000-05-11 |
EP1619202B1 (de) | 2008-08-20 |
DE69929533T2 (de) | 2006-09-07 |
EP1619202A2 (de) | 2006-01-25 |
WO2000026249A1 (en) | 2000-05-11 |
US7326767B1 (en) | 2008-02-05 |
DE69939406D1 (de) | 2008-10-02 |
DE69929533D1 (de) | 2006-04-06 |
US8529904B2 (en) | 2013-09-10 |
AU6479799A (en) | 2000-05-22 |
EP1619202A3 (de) | 2006-03-08 |
AU770752B2 (en) | 2004-03-04 |
JP2003500004A (ja) | 2003-01-07 |
US20080159993A1 (en) | 2008-07-03 |
EP1127068A1 (de) | 2001-08-29 |
NZ511454A (en) | 2004-01-30 |
ZA200103943B (en) | 2003-08-15 |
EP1127068B1 (de) | 2006-01-18 |
CA2348956C (en) | 2012-05-22 |
ATE316099T1 (de) | 2006-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69929533D1 (de) | Immunotherapeutische methoden mit verwendung von wt-1 and gata-1 epitopen | |
DK0397633T3 (da) | Fibronectinbindende protein samt fremstilling deraf | |
ATE475675T1 (de) | Verwendung prokariotischer pest-ähnlicher peptide zur verstärkung der immunogenität von antigenen | |
ES550943A0 (es) | Un procedimiento para preparar una proteina de fusion derivada de la secuencia de aminoacidos de la preprorrelaxina humana. | |
DE60132075D1 (de) | Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren | |
DK179290D0 (da) | Rekombinante cmv-neutraliserende proteiner | |
YU49126B (sh) | Varijantni cd44-površinski proteini, dna-sekvence koje ih kodiraju i antitela protiv ovih proteina | |
ES2129487T3 (es) | Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion. | |
DE60133287D1 (de) | Tumorantigen | |
DK295188D0 (da) | Fibronectinbindende protein og fremgangsmaade til fremstilling heraf | |
NO970113D0 (no) | Kollagenbindende protein eller polypeptid | |
NO20005081D0 (no) | Et polypeptid inneholdende aminosyren fra et N-terminalt kolinbindende protein A-truncat, vaksine avledet derfra og anvendelser derav | |
WO1996002572A3 (fr) | Sequence polypeptidique antigenique du facteur viii, fragments et/ou epitopes de celle-ci | |
SE8801723D0 (sv) | Fibronectin binding protein as well as its preparation | |
DE59109235D1 (de) | Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung | |
WO1999031229A3 (en) | Peptides and nucleic acids derived from eisenia foetida and the use thereof | |
DE69534738D1 (de) | Leukocyten-aktivierender Faktor | |
ES553374A0 (es) | Un procedimiento para mejorar la produccion de un polipeptido deseado en un hospedante transformado con una molecula de adn recombinantes. | |
ATE201697T1 (de) | Antigenen peptide mit glycinsubstitution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |